OWC Pharmaceutical Research Corp (OWCP)

[stockseekerok]

The business of OWC will be based upon the creation of an Israeli Cannabis Institute for Research working together with major established Israeli hospitals and universities. The focus of OWC will involve medical research on the efficacy of cannabis on the treatment of, among other illnesses/medical conditions:
- PTSD;
- diabetes;
- Parkinson disease;
- children's epilepsy;
- prostate cancer;
- psoriasis; and
- topical treatment of burns.

The Registrant plans for OWC to be at the forefront of compliance with international regulatory protocols and the development and improvement of strains of cannabis specifically designed for medical treatment. OWC's business plan is to: (i) establish regulated medical cannabis systems for medical institutions based upon the regulated Israeli model; (ii) promote the establishment of local and international research facilities for the study and commercial application of medical cannabis; (iii) establish a medical cannabis research institute in Israel in compliance with existing Israeli laws and regulations with international branches; (iv) raise grants for medical cannabis research; (v) develop new use and means of administration of medical cannabis.

The Registrant will continue to work closely with GUMI Tel Aviv Ltd, a major, privately-held Israeli technology company ("GUMI") in the manufacture and marketing of commercial model(s) of the Registrant's Patented Percussion Device, its core business.